Tag: Revlimid

Natco Pharma unveils additional strengths of generic Revlimid in U.S.

Natco Pharma unveils additional strengths of generic Revlimid in U.S.

cpooldigitalLeave a Comment on Natco Pharma unveils additional strengths of generic Revlimid in U.S.

A bottle of Revlimid seen at a store in Utah. File photo | Photo Credit: Reuters Natco Pharma has launched its generic version of Celgene Corporation’s cancer drug Revlimid (lenalidomide capsules) in additional strengths in the United States. The 2.5 mg and 20 mg strengths of the prescription medicine used in adults for the treatment […]

Continue Reading
Dr. Reddy’s faces anti-trust litigation in U.S. over cancer drug Revlimid

Dr. Reddy’s faces anti-trust litigation in U.S. over cancer drug Revlimid

cpooldigitalLeave a Comment on Dr. Reddy’s faces anti-trust litigation in U.S. over cancer drug Revlimid

A bottle of Revlimid and pills are seen at the Huntsman Cancer Institute at the University of Utah in Salt Lake City, Utah, U.S. File | Photo Credit: Reuters Dr. Reddy’s Laboratories and a few other drugmakers have been named defendants in a complaint filed in the U.S. under the Federal and State antitrust laws […]

Continue Reading